Abbott Labs unleashes layoffs; Helix Medical buys MedVenture Technology;

 @FierceMedDev: Boston Scientific's Q3 2012 earnings report has very few bright spots, as restructuring continues. More | Follow @FierceMedDev

 @MarkHFierce: Computer viruses are running wild in hospital medical devices, MIT Technology Review reports. More | Follow @MarkHFierce

 @DamianFierce: Stryker is scaling back its profit projections after a disappointing third quarter. More | Follow @DamianFierce

> Abbott Laboratories ($ABT) has laid off an additional 550 people, affecting its diagnostic, medical devices, pharmaceutical and nutrition units. Story

> Paradigm Spine gained FDA approval for a device designed to treat moderate to severe spinal stenosis whether or not back pain is involved. Item

> Helix Medical, a medical device and healthcare industry manufacturer, has acquired MedVenture Technology from private equity firm Ampersand Capital Partners. MedVenture designs, develops and makes medical devices. Neither side disclosed financial terms. Release

> A man with Duchenne muscular dystrophy is among the first U.S. patients with the disease to receive a ventricular assist device. Item

> Neuro Kinetics won a new $2.4 million Department of Defense grant to develop new diagnostic tests for brain injuries stemming from combat. Story

> Device maker Tornier ($TRNX) will announce its 2012 third quarter earnings on Monday, Nov. 5, 2012. Release

> EarlySense gained FDA approval for its new oximetry bedside monitor. Story

> LabCorp ($LH) again reduced its 2012 profit outlook after posting meager growth in the third quarter. Article

Biotech News

 @FierceBiotech: The ax drops on hundreds at Human Genome Sciences in wake of GSK buyout. More | Follow @FierceBiotech

 @JohnCFierce: FDA is extending review of BG-12 (MS). Drat. Thought we'd have an approval this year. Big drug for Biogen. More | Follow @JohnCFierce

> BioCryst scoops up early-stage hep C drugs in $101M Presidio acquisition. Article

> Aegerion wins lopsided FDA panel vote backing rare cholesterol disease drug. News

> Abbott slammed after deaths scuttle PhIII kidney disease program. Story

> Actelion abstract details 'promising' macitentan data. Item

Pharma News

@FiercePharma: NYT explores the sorry state of some pharma manufacturing plants--and their contributions to drug shortages. More | Follow @FiercePharma

> Abbott adds 550 to layoffs toll as split-up nears. Story

> Facing Monday trial, Pfizer settles bellwether Chantix case. Article

> Teva, HGS beef up layoff plans in U.S. News

Vaccines News

> J. Craig Venter explores printable vaccines. Article

> GSK recalls infant vaccine in Australia. Story

> University of Minnesota researchers call for better flu vaccine. More

> Study: HPV vaccine does not increase signs of sexual activity. More

> Special Report: 10 promising therapeutic vaccines 2012. Report

Pharma Manufacturing News

> Ben Venue begins limited manufacturing at Ohio drug plant. News

> Criminal investigators search site linked to meningitis outbreak. Report

> Watson to sell manufacturing tech to seal $5.9B Actavis deal. Story

> FDA warns stem cell outfit Celltex about GMP no-nos. Article

Suggested Articles

Sanofi will look to pull back from its three-year-old relationship with Verily and their virtual diabetes clinic, Onduo.

AstraZeneca is linking up with DeepMatter, a big data firm focused on achieving reproducibility in chemistry, to help improve its compound synthesis.

Boehringer Ingelheim tapped Healx to help identify new drug indications and leverage its AI to explore R&D options in neurological diseases.